COMP <GO>
GMAB vs ONC // EV/EBITDA & P/E VALUATION
Genmab A/S ADS (NASDAQ) VS. BeOne Medicines Ltd. (NASDAQ) • 15-METRIC TALLY: GMAB 6
— ONC 6
▲ EV/EBITDA & P/E VALUATION LEADER: GMAB
LAST: $57.06 (+1.01%) • MKT CAP: $35.25B
valuation
21.0x
LAST: $370.33 (-0.33%) • MKT CAP: $42.25B
valuation
63.9x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GMAB VS. ONC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GMAB | ONC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 87.50% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.90% | 10.50% | -0.60 | ONC | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 21.0x | 63.9x | -42.90 | GMAB | /valuation <GO> |
| Free Cash Flow Yield | 2.21% | 2.23% | -0.02 | ONC | /fcf-yield <GO> |
| Operating Margin | 13.90% | 8.40% | +5.50 | GMAB | /operating-margins <GO> |
| Net Profit Margin | 10.90% | 5.40% | +5.50 | GMAB | /net-margins <GO> |
| Revenue Growth (YoY) | 22.00% | 40.20% | -18.20 | ONC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.74 | 6.68 | -2.94 | ONC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 9/9 | -1.00 | ONC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 85.2 | 53.6 | +31.60 | GMAB | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.09 | 0.98 | +0.11 | GMAB | /macro-sensitivity <GO> |
| Forward P/E Multiple | 27.6x | 123.6x | -96.00 | GMAB | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $35.25B | $42.25B | -$6.99B | ONC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GMAB REV | ONC REV | GMAB GROSS % | ONC GROSS % | GMAB FCF | ONC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $5.34B | — | 87.5% | — | $941.7M |
| FY 2024 | — | $3.81B | — | 84.4% | — | -$633.3M |
| FY 2023 | — | $2.46B | — | — | — | -$1.27B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GMAB // BETA 1.09
ONC // BETA 0.98